ASX:4DXHealthcare Services
4DMedical (ASX:4DX) Valuation Check After Half Year Results And CT:VQ Growth Opportunity
4DMedical (ASX:4DX) is back in focus after its half-year results, where the company reported an improved adjusted net loss, a solid cash position, and highlighted its recently approved CT:VQ product.
See our latest analysis for 4DMedical.
At a latest share price of A$4.00, 4DMedical has seen a 12.68% 1 month share price return and a 133.92% 3 month share price return, while its 1 year total shareholder return is very large. This suggests momentum has been building around the CT:VQ rollout and...